Envoy Medical, Inc.·4

Oct 3, 9:46 PM ET

Hirsch Daniel J. 4

4 · Envoy Medical, Inc. · Filed Oct 3, 2023

Insider Transaction Report

Form 4
Period: 2023-09-29
Hirsch Daniel J.
DirectorCFO and Corporate Secretary
Transactions
  • Conversion

    Class B Common Stock, par value $0.0001 per share

    2023-09-2925,0000 total
    Class A Common Stock, par value $0.0001 per share (25,000 underlying)
  • Conversion

    Class A Common Stock, par value $0.0001 per share

    2023-09-29+25,00025,000 total
Footnotes (1)
  • [F1]On September 29, 2023, in connection with the consummation of the business combination (the "Business Combination") between Anzu Special Acquisition Corp I ("Anzu") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Mr. Hirsch resigned as Chief Financial Officer, Corporate Secretary, and Director of Anzu.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES